ZOMACTON Powder and Solvent for Solution for Injection 10mg Singapore - English - HSA (Health Sciences Authority)

zomacton powder and solvent for solution for injection 10mg

ferring pharmaceuticals private limited - somatropin - injection, powder, for solution - 10.0 mg - somatropin 10.0 mg

ZOMACTON Powder and Solvent for Solution for Injection 4 mg Singapore - English - HSA (Health Sciences Authority)

zomacton powder and solvent for solution for injection 4 mg

ferring pharmaceuticals private limited - somatropin - injection, powder, for solution - 4 mg - somatropin 4 mg

MINIRIN ORAL LYOPHILISATE 240 MCG Singapore - English - HSA (Health Sciences Authority)

minirin oral lyophilisate 240 mcg

ferring pharmaceuticals private limited - desmopressin acetate 270 mcg eqv to desmopressin - tablet, orally disintegrating - desmopressin acetate 270 mcg eqv to desmopressin 240 mcg

NOCDURNA ORAL LYOPHILISATE 25MCG Singapore - English - HSA (Health Sciences Authority)

nocdurna oral lyophilisate 25mcg

ferring pharmaceuticals private limited - desmopressin acetate 28mcg eqv to desmopressin - tablet, orally disintegrating - desmopressin acetate 28mcg eqv to desmopressin 25mcg

NOCDURNA ORAL LYOPHILISATE 50MCG Singapore - English - HSA (Health Sciences Authority)

nocdurna oral lyophilisate 50mcg

ferring pharmaceuticals private limited - desmopressin acetate 56mcg eqv to desmopressin - tablet, orally disintegrating - desmopressin acetate 56mcg eqv to desmopressin 50mcg

Tractocile European Union - English - EMA (European Medicines Agency)

tractocile

ferring pharmaceuticals a/s - atosiban (as acetate) - premature birth - other gynecologicals - tractotile is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.

DECAPEPTYL triptorelin acetate 100 micrograms/1 mL solution for injection in 1mL pre-filled syringe with integrated needle Australia - English - Department of Health (Therapeutic Goods Administration)

decapeptyl triptorelin acetate 100 micrograms/1 ml solution for injection in 1ml pre-filled syringe with integrated needle

ferring pharmaceuticals pty ltd - triptorelin acetate, quantity: 100 microgram (equivalent: triptorelin, qty 95.6 microgram/ml) - injection, solution - excipient ingredients: glacial acetic acid; water for injections; sodium chloride - decapeptyl 100 micrograms/1 ml is indicated for down-regulation and prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation for assisted reproductive technologies (art).,in clinical trials decapeptyl 100 micrograms/1 ml has been used in cycles where urinary and recombinant human follicle stimulating hormone (fsh) as well as human menopausal gonadotrophin (hmg) were used for stimulation.

MINIRIN MELT desmopressin 240 micrograms sublingual wafers blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

minirin melt desmopressin 240 micrograms sublingual wafers blister pack

ferring pharmaceuticals pty ltd - desmopressin, quantity: 240 microgram (equivalent: desmopressin acetate, qty 272 microgram) - wafer - excipient ingredients: mannitol; citric acid; gelatin - 1- cranial diabetes insipidus. 2- primary nocturnal enuresis in patients from 6 years of age with normal ability to concentrate urine who are refractory to an enuresis alarm or in whom the enuresis alarm is contraindicated or inappropriate.

MINIRIN MELT desmopressin 120 micrograms sublingual wafers blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

minirin melt desmopressin 120 micrograms sublingual wafers blister pack

ferring pharmaceuticals pty ltd - desmopressin, quantity: 120 microgram (equivalent: desmopressin acetate, qty 136 microgram) - wafer - excipient ingredients: citric acid; mannitol; gelatin - 1- cranial diabetes insipidus. 2- primary nocturnal enuresis in patients from 6 years of age with normal ability to concentrate urine who are refractory to an enuresis alarm or in whom the enuresis alarm is contraindicated or inappropriate.